Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver
Massarrat, S.; Jordan, G.; Sahrhage, G.; Korb, G.; Bode, J.C.; Dölle, W.
Acta Hepato-Gastroenterologica 21(3): 176-186
1974
ISSN/ISBN: 0300-970X PMID: 4450977 Document Number: 73889
Document emailed within 1 workday
Related Documents
Jin, H-Bin.; Gu, Z-Ying.; Yu, C-Hui.; Li, Y-Ming. 2005: Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(3): 389-392Buranakitjaroen, P.; Phoojaroenchanachai, M. 2012: Changes of microalbuminuria in nondiabetic hypertensive patients after one year follow-up Journal of the Medical Association of Thailand 95 Suppl. 2: S179-S188
Niriella, M.A.; Pathmeswaran, A.; De Silva, S.T.; Kasturiratna, A.; Perera, R.; Subasinghe, C.E.; Kodisinghe, K.; Piyaratna, C.; Rishikesawan, V.; Dassanayaka, A.S.; De Silva, A.P.; Wickramasinghe, R.; Takeuchi, F.; Kato, N.; de Silva, H.J. 2017: Incidence and risk factors for non-alcoholic fatty liver disease: a 7-year follow-up study among urban, adult Sri Lankans Liver International: Official Journal of the International Association for the Study of the Liver 37(11): 1715-1722
Lin, S.C.; Shih, S.C.; Kao, C.R.; Chou, S.Y. 1995: Prevalence of antibodies to hepatitis C virus in patients with nonalcoholic fatty liver Zhonghua Yi Xue Za Zhi 56(2): 80-85
Casoinic, F.; Sâmpelean, D.; Bădău, C.ăt.ăl.; Prună, L. 2009: Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients Romanian Journal of Internal Medicine 47(1): 55-59
Giday, S.A.; Ashiny, Z.; Naab, T.; Smoot, D.; Banks, A. 2006: Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients Journal of the National Medical Association 98(10): 1613-1615
Kuchmin, A.N.; Rezvan, V.V.; Evsiukov, K.B.; Fomin, A.A.; Karshieva, A.V.; Butikov, V.P. 2010: Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction Voenno-Meditsinskii Zhurnal 331(6): 20-26
Kolesnikova, O. 2012: Relationship gene polymorphism adipor1 with cardiovascular risk in patients with nonalcoholic fatty liver disease Georgian Medical News 213: 40-44
Wu, P.; Shu, Y.; Li, M.; Luo, H.; Zhang, G.; Tan, S. 2015: Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease Zhonghua Liu Xing Bing Xue Za Zhi 36(12): 1415-1418
Chernyak, O.O.; Sentsova, T.B.; Vorozhko, I.V.; Tutelyan, V.A.; Gapparova, K.M.; Isakov, V.A. 2015: Genomic, proteomic and metabolomic predictors of nonalcoholic fatty liver disease development in obese patients. Part i Voprosy Pitaniia 84(4): 18-24
Zvenigorodskaya, L.A.; Petrakov, A.V.; Nilova, T.V.; Varvanina, G.G.; Lychkova, A.E. 2016: The Role of Bile Acids in the Regulation of Lipid and Carbohydrate Metabolism in Patients with Nonalcoholic Fatty Liver Disease and Diabetes Type2 Eksperimental'naia i Klinicheskaia Gastroenterologiia 11: 31-34
Chen, J.; Zheng, R.-D.; Xu, C.-R.; Wu, W.-P. 2009: Expression and significance of liver X receptor-alpha in nonalcoholic fatty liver disease in rats Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(4): 265-268
Spahr, L. 2011: Nonalcoholic fatty liver Revue Medicale Suisse 7(279): 227
Chen, L.-l.; Deng, X.-q.; Li, N.-x. 2007: Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats Zhonghua Yi Xue Za Zhi 87(20): 1434-1437
Grigor'eva, I.N. 2011: UDCA in the treatment of nonalcoholic fatty liver disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 9: 125-131
Grigor'eva, I.N. 2011: UDCA in the treatment of nonalcoholic fatty liver disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 11: 79-85
Pérez Blanco, L.A.; Vilar Gómez, E.; Martínez Pérez, Y.; Calzadilla Bertot, L. 2013: Nonalcoholic fatty liver disease. a current perspective Acta Gastroenterologica Latinoamericana 43(3): 254-260
Podymova, S.D. 2016: [The Modern View on Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 5: 74-82
Drapkina, O.M.; Deeva, T.A.; Volkova, N.P.; Ivashkin, V.T. 2014: [Current approaches to diagnosing and treating nonalcoholic fatty liver disease Terapevticheskii Arkhiv 86(10): 116-123
Prompila, N.; Wittayalertpanya, S.; Komolmit, P. 2008: Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease Journal of the Medical Association of Thailand 91(5): 733-738